Previous 10 | Next 10 |
RedHill Biopharma Announces Insider Buying PR Newswire TEL-AVIV , Israel & RALEIGH, N.C , Oct. 18, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced tha...
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034 The patent is directed to the Talicia ® formulation and pharmaceutical kits for use in the treatment of H. pylori infection The new patent, valid through 2034, will be the fifth ...
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034 - The patent is directed to the Talicia® formulation and pharmaceutical kits for use in the treatment of H. pylori infection - The new patent, valid through 2034, will be t...
RedHill Biopharma's Talicia ® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia ® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no prior authorization is an important expansion of coverage for California patie...
RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no prior authorization is an important expansion of coverage for California p...
RedHill Biopharma (NASDAQ: RDHL) was a standout stock on a gloomy Monday for the market. The biotech's shares rose by just under 12% on positive and not entirely expected news about its top pipeline drug. Monday morning, RedHill announced that its opaganib produced a 62% statist...
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients 62% statistically significant reduction in mortality shown for moderately severe COVID-19 patients group treated with opa...
RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Aurobindo The settlement agreement with Aurobindo brings closure to all presently pending Movantik® patent litigation brought pursuant to The Drug Price Competition and Patent Term Restoration A...
While state governments in the U.S. have largely loosened restrictions on gambling in recent years, there are reports that Macau might be taking the opposite approach. Speculation of stepped-up oversight in that Chinese market sent Wynn Resorts (NASDAQ:WYNN), Melco Resorts & Entertainment...
Gainers: Communications Systems (NASDAQ:JCS) +33%. BELLUS Health (NASDAQ:BLU) +20%. Matinas BioPharma (NYSE:MTNB) +19%. Onion Global (NYSE:OG) +18%. FuelCell Energy (NASDAQ:FCEL) +17%. Silverback Therapeutics (NASDAQ:SBTX) +16%. DatChat (NASDAQ:DATS) +15%. Calumet (NASDAQ:CLMT) +15%. Ada...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...